Author

H. Ou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. Zhao· 1 shared D. Dong· 1 shared D. Zhao· 1 shared H. He· 1 shared H. Ma· 1 shared J. Ruan· 1 shared L. Lai· 1 shared M. Ding· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Zhao

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Two subtypes of GTPase-activating proteins coordinate tip growth and cell size regulation in Physcomitrium patens

J. Ruan, L. Lai, H. Ou, P. Yi

This study identifies two subtypes of GTPase-activating proteins that regulate tip growth and cell size in moss by modulating ROP activity and membrane organization.

bioRxiv · Jun 15, 2023Plant Biology

Interleukin-16/STAT6 recruits CBP/p300 to upregulate TIMP-3 and promote atherosclerotic plaque stability

H. He, M. Ding, Y. Zhu, T. Jiang, D. Dong, X. Xu, H. Ou

This study shows IL-16 promotes atherosclerotic plaque stability by upregulating TIMP-3 through STAT6 and CBP/p300 recruitment.

bioRxiv · May 23, 2023 · PreprintPathology

Potent in vitro Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain

H. Ma, W. Zeng, X. Meng, X. Huang, Y. Yang, D. Zhao, P. Zhou, X. Wang, C. Zhao, Y. Sun, P. Wang, H. Ou, X. Hu, Y. Xiang, T. Jin

This paper develops and characterizes SARS-CoV-2 RBD-specific alpaca nanobodies, showing improved binding affinity and neutralizing potency through bivalent engineering.

Journal of Virology · Apr 26, 2021Peer-reviewedImmunology